Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Pancreatic Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
25 drugs · 152 active trials
4 drugs · 116 active trials
8 drugs · 223 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 19 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Gemcitabine | Approved | Phase 4 | 109 | 50 | 69 | 560 | 3 | US | Aug 4, 2011 | 1997-07 |
| Fluorouracil | Approved | Phase 4 | 41 | 20 | 25 | 150 | 1 | US | Feb 20, 2026 | 1995-08 |
| Irinotecan | Approved | Phase 3 | 34 | 16 | 11 | 89 | 2 | EU, US | Oct 22, 2015 | 1998-04 |
| Capecitabine | Approved | Phase 3 | 17 | 6 | 13 | 109 | 1 | US | Apr 30, 1998 | 2001-12 |
| Olaparib | Approved | Phase 3 | 11 | 4 | 1 | 22 | 1 | US | Aug 17, 2017 | 2011-01 |
| Paclitaxel | Approved | Phase 3 | 8 | 5 | 2 | 34 | 3 | US | Jan 7, 2005 | 1998-11 |
| Erlotinib Hydrochloride | Approved | Phase 3 | 2 | 0 | 3 | 24 | 1 | US | Nov 5, 2019 | Jul 23, 2001 |
| Erlotinib | Approved | Phase 4 | 1 | 1 | 2 | 31 | 2 | US | Aug 28, 2015 | 2005-07 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.